Matthew G. Bursavich, Ph.D.

Affiliations: 
2002 University of Wisconsin, Madison, Madison, WI 
Area:
aspartic protease
Google:
"Matthew Bursavich"
Mean distance: 8.73
 
SNBCP

Parents

Sign in to add mentor
Daniel H. Rich grad student 2002 UW Madison
 (Design and synthesis of non-peptide peptidomimetic inhibitors of the aspartic peptidases.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Blain JF, Bursavich MG, Freeman EA, et al. (2016) Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease. Alzheimer's Research & Therapy. 8: 34
Vijay Kumar D, Hoarau C, Bursavich M, et al. (2012) Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 22: 4377-85
Gilbert AM, Bursavich MG, Lombardi S, et al. (2011) 3-(Pyridin-2-yl-ethynyl)benzamide metabotropic glutamate receptor 5 negative allosteric modulators: hit to lead studies. Bioorganic & Medicinal Chemistry Letters. 21: 195-9
Cole DC, Olland AM, Jacob J, et al. (2010) Identification and characterization of acidic mammalian chitinase inhibitors. Journal of Medicinal Chemistry. 53: 6122-8
Bursavich MG, Brooijmans N, Feldberg L, et al. (2010) Novel benzofuran-3-one indole inhibitors of PI3 kinase-alpha and the mammalian target of rapamycin: hit to lead studies. Bioorganic & Medicinal Chemistry Letters. 20: 2586-90
Tsou HR, MacEwan G, Birnberg G, et al. (2010) Discovery and optimization of 2-(4-substituted-pyrrolo[2,3-b]pyridin-3-yl)methylene-4-hydroxybenzofuran-3(2H)-ones as potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR). Bioorganic & Medicinal Chemistry Letters. 20: 2321-5
Bursavich MG, Parker DP, Willardsen JA, et al. (2010) 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97). Bioorganic & Medicinal Chemistry Letters. 20: 1677-9
Gilbert AM, Nowak P, Brooijmans N, et al. (2010) Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-alpha: Hit to lead studies. Bioorganic & Medicinal Chemistry Letters. 20: 636-9
Venkatesan AM, Dehnhardt CM, Chen Z, et al. (2010) Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 653-6
Gilbert AM, Bursavich MG, Alon N, et al. (2010) Hit to lead studies on (hetero)arylpyrimidines--agonists of the canonical Wnt-beta-catenin cellular messaging system. Bioorganic & Medicinal Chemistry Letters. 20: 366-70
See more...